vs

Side-by-side financial comparison of ENNIS, INC. (EBF) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $100.2M, roughly 1.4× ENNIS, INC.). ENNIS, INC. runs the higher net margin — 10.8% vs -5.3%, a 16.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 0.4%). ENNIS, INC. produced more free cash flow last quarter ($15.7M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 1.4%).

ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

EBF vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.4× larger
TOI
$142.0M
$100.2M
EBF
Growing faster (revenue YoY)
TOI
TOI
+41.2% gap
TOI
41.6%
0.4%
EBF
Higher net margin
EBF
EBF
16.1% more per $
EBF
10.8%
-5.3%
TOI
More free cash flow
EBF
EBF
$13.5M more FCF
EBF
$15.7M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
1.4%
EBF

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
EBF
EBF
TOI
TOI
Revenue
$100.2M
$142.0M
Net Profit
$10.8M
$-7.5M
Gross Margin
31.9%
Operating Margin
15.0%
-4.9%
Net Margin
10.8%
-5.3%
Revenue YoY
0.4%
41.6%
Net Profit YoY
6.1%
43.0%
EPS (diluted)
$0.42
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EBF
EBF
TOI
TOI
Q4 25
$100.2M
$142.0M
Q3 25
$98.7M
$136.6M
Q2 25
$97.2M
$119.8M
Q1 25
$92.7M
$104.4M
Q4 24
$99.8M
$100.3M
Q3 24
$99.0M
$99.9M
Q2 24
$103.1M
$98.6M
Q1 24
$97.4M
$94.7M
Net Profit
EBF
EBF
TOI
TOI
Q4 25
$10.8M
$-7.5M
Q3 25
$13.2M
$-16.5M
Q2 25
$9.8M
$-17.0M
Q1 25
$9.0M
$-19.6M
Q4 24
$10.2M
$-13.2M
Q3 24
$10.3M
$-16.1M
Q2 24
$10.7M
$-15.5M
Q1 24
$10.1M
$-19.9M
Gross Margin
EBF
EBF
TOI
TOI
Q4 25
31.9%
Q3 25
30.5%
Q2 25
31.1%
Q1 25
29.5%
Q4 24
29.3%
Q3 24
30.1%
Q2 24
30.0%
Q1 24
28.4%
Operating Margin
EBF
EBF
TOI
TOI
Q4 25
15.0%
-4.9%
Q3 25
12.5%
-5.9%
Q2 25
13.7%
-9.4%
Q1 25
13.0%
-9.5%
Q4 24
13.1%
-11.9%
Q3 24
13.3%
-13.9%
Q2 24
13.3%
-16.6%
Q1 24
13.3%
-19.0%
Net Margin
EBF
EBF
TOI
TOI
Q4 25
10.8%
-5.3%
Q3 25
13.3%
-12.1%
Q2 25
10.1%
-14.2%
Q1 25
9.7%
-18.8%
Q4 24
10.2%
-13.1%
Q3 24
10.4%
-16.1%
Q2 24
10.4%
-15.7%
Q1 24
10.4%
-21.0%
EPS (diluted)
EBF
EBF
TOI
TOI
Q4 25
$0.42
$-0.04
Q3 25
$0.51
$-0.14
Q2 25
$0.38
$-0.15
Q1 25
$0.34
$-0.21
Q4 24
$0.39
$-0.14
Q3 24
$0.40
$-0.18
Q2 24
$0.41
$-0.17
Q1 24
$0.39
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EBF
EBF
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$31.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$304.8M
$-15.7M
Total Assets
$354.3M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EBF
EBF
TOI
TOI
Q4 25
$31.3M
Q3 25
$31.9M
Q2 25
$32.6M
Q1 25
$72.5M
Q4 24
$68.6M
Q3 24
$122.6M
Q2 24
$123.7M
$9.9M
Q1 24
$110.9M
$29.8M
Stockholders' Equity
EBF
EBF
TOI
TOI
Q4 25
$304.8M
$-15.7M
Q3 25
$305.4M
$-12.3M
Q2 25
$301.2M
$-9.0M
Q1 25
$302.0M
$5.1M
Q4 24
$297.7M
$3.6M
Q3 24
$358.4M
$15.5M
Q2 24
$354.4M
$29.2M
Q1 24
$349.8M
$41.3M
Total Assets
EBF
EBF
TOI
TOI
Q4 25
$354.3M
$164.7M
Q3 25
$361.8M
$163.6M
Q2 25
$361.7M
$159.8M
Q1 25
$348.9M
$164.0M
Q4 24
$346.1M
$172.7M
Q3 24
$406.8M
$179.2M
Q2 24
$406.2M
$179.6M
Q1 24
$399.2M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EBF
EBF
TOI
TOI
Operating Cash FlowLast quarter
$16.4M
$3.2M
Free Cash FlowOCF − Capex
$15.7M
$2.2M
FCF MarginFCF / Revenue
15.7%
1.5%
Capex IntensityCapex / Revenue
0.7%
0.7%
Cash ConversionOCF / Net Profit
1.52×
TTM Free Cash FlowTrailing 4 quarters
$42.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EBF
EBF
TOI
TOI
Q4 25
$16.4M
$3.2M
Q3 25
$10.5M
$-12.6M
Q2 25
$8.0M
$-10.2M
Q1 25
$12.8M
$-5.0M
Q4 24
$18.2M
$4.2M
Q3 24
$11.8M
$819.0K
Q2 24
$23.1M
$-15.7M
Q1 24
$16.6M
$-15.9M
Free Cash Flow
EBF
EBF
TOI
TOI
Q4 25
$15.7M
$2.2M
Q3 25
$9.0M
$-13.2M
Q2 25
$6.6M
$-11.4M
Q1 25
$11.1M
$-5.3M
Q4 24
$17.5M
$2.4M
Q3 24
$10.7M
$417.0K
Q2 24
$20.6M
$-17.5M
Q1 24
$15.0M
$-16.5M
FCF Margin
EBF
EBF
TOI
TOI
Q4 25
15.7%
1.5%
Q3 25
9.2%
-9.7%
Q2 25
6.8%
-9.5%
Q1 25
12.0%
-5.1%
Q4 24
17.6%
2.4%
Q3 24
10.8%
0.4%
Q2 24
20.0%
-17.7%
Q1 24
15.3%
-17.4%
Capex Intensity
EBF
EBF
TOI
TOI
Q4 25
0.7%
0.7%
Q3 25
1.4%
0.4%
Q2 25
1.4%
1.0%
Q1 25
1.8%
0.3%
Q4 24
0.6%
1.8%
Q3 24
1.1%
0.4%
Q2 24
2.4%
1.9%
Q1 24
1.7%
0.6%
Cash Conversion
EBF
EBF
TOI
TOI
Q4 25
1.52×
Q3 25
0.80×
Q2 25
0.81×
Q1 25
1.41×
Q4 24
1.78×
Q3 24
1.15×
Q2 24
2.16×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EBF
EBF

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons